News Landfar Bio-medicine Co., Ltd

Equities

000504

CNE000000263

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
7.89 ^CNY	+10.04%		+20.27%	-31.98%

Apr. 29	Landfar Bio-medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 11	Chongqing International Trust Co., Ltd. acquired 10.8% stake in Landfar Bio-medicine Co., Ltd from Shanghai Heping Dazong Equity Investment Fund Management Co., Ltd for CNY 0.03 million.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Landfar Bio-medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Chongqing International Trust Co., Ltd. acquired 10.8% stake in Landfar Bio-medicine Co., Ltd from Shanghai Heping Dazong Equity Investment Fund Management Co., Ltd for CNY 0.03 million.	Apr. 10	CI
Landfar Bio-medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Landfar Bio-medicine Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Landfar Bio-medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Landfar Bio Medicine’s Controlling Shareholder Boosts Stake to 30%	23-04-27	MT
Landfar Bio-medicine Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-20	CI
Landfar Bio-medicine Co., Ltd completed the acquisition of additional 29% stake in Hunan Nanhua Amspring Biotechnology Co., Ltd. from Wang Yang, Luo Yi and Changsha Aishi Pulin Information Consulting Co., Ltd. for CNY 9.7 million.	22-12-09	CI
NanHua Bio-medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-30	CI
NanHua Bio-medicine Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-29	CI
NanHua Bio-medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
NanHua Bio-medicine Co., Ltd announced that it expects to receive CNY 275.999987 million in funding from Hunan Chasing Fund Management Co., Ltd.	22-03-21	CI
NanHua Bio-medicine Co., Ltd signed a letter of intent to acquire Medicine-related assets from YanAn Bicon Pharmaceutical Listed Company.	21-12-09	CI
NanHua Bio-medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Nanhua Bio-Medicine Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-30	CI
Nanhua Bio-Medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-28	CI
Nanhua Bio-Medicine Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-30	CI
Nanhua Bio-Medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-28	CI
NanHua Bio-medicine Co., Ltd's Equity Buyback announced on October 29, 2019, has expired.	20-10-27	CI
Hunan Finance Industry Fund Management Co., Ltd. cancelled the acquisition of 25.58% stake in NanHua Bio-medicine Co., Ltd. from Hunan Trust Co., Ltd.	20-10-09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Landfar Bio-medicine Co., Ltd

Equities

000504

CNE000000263

Summary

Filters